Bitter Pill. Lawrence Diller.
by Diller, Lawrence; ProQuest Information and Learning Company.
Series: SIRS Enduring Issues 2006Article 66Health. Publisher: Psychotherapy Networker, 2005ISSN: 1522-323X;.Subject(s): Attention-deficit hyperactivity disorder | Drug abuse | Psychiatry -- Research | Psychopharmacology | RitalinDDC classification: 050 Summary: This article discusses the controversial finding by research psychologist Nadine Lambert that the "use of Ritalin, one of the most routinely prescribed drugs for children in America, might contribute to later drug abuse," (PSYCHOTHERAPY NETWORKER) noting that Lambert's study has been largely criticized, rebutted, and dismissed by members of the psychiatry community. The author also proposes that the reason "the National Institute on Drug Abuse (NIDA) has refused funding to Nadine Lambert, either to conduct further follow-up on her subjects or to analyze her current data more closely" is because of "the politics of American psychiatry and the influence of the multibillion-dollar psychopharmacology industry on scientific debates within the field."| Item type | Current location | Call number | Status | Date due |
|---|---|---|---|---|
Books
|
High School - old - to delete | REF SIRS 2006 Health Article 66 (Browse shelf) | Available |
Articles Contained in SIRS Enduring Issues 2006.
Originally Published: Bitter Pill, Jan./Feb. 2005; pp. 56+.
This article discusses the controversial finding by research psychologist Nadine Lambert that the "use of Ritalin, one of the most routinely prescribed drugs for children in America, might contribute to later drug abuse," (PSYCHOTHERAPY NETWORKER) noting that Lambert's study has been largely criticized, rebutted, and dismissed by members of the psychiatry community. The author also proposes that the reason "the National Institute on Drug Abuse (NIDA) has refused funding to Nadine Lambert, either to conduct further follow-up on her subjects or to analyze her current data more closely" is because of "the politics of American psychiatry and the influence of the multibillion-dollar psychopharmacology industry on scientific debates within the field."
Records created from non-MARC resource.
There are no comments for this item.